NCT02288832View on ClinicalTrials.gov

"Medico-economic Impact of Screening Atopobium Vaginae and Gardnerella Vaginalis in Molecular Biology by Point-of-care During Pregnancy"

PHASE2/PHASE3CompletedINTERVENTIONAL

Enrollment

6,800

Participants

Timeline

Start Date

March 6, 2015

Primary Completion Date

July 1, 2018

Study Completion Date

October 21, 2022

Conditions

Low Risk of Preterm Delivery

Interventions

OTHER

-self-collected vaginal samples

DRUG

zithromax

OTHER

usual practices

Trial Locations (2)

13354

Assistance Publique Hopitaux de Marseille, Marseille

13915

Hôpital Nord Assistance Publique Hôpitaux de Marseille, Marseille

All Listed Sponsors

lead

Assistance Publique Hopitaux De Marseille

OTHER

NCT02288832 - "Medico-economic Impact of Screening Atopobium Vaginae and Gardnerella Vaginalis in Molecular Biology by Point-of-care During Pregnancy" | Biotech Hunter | Biotech Hunter